190 related articles for article (PubMed ID: 22668652)
1. [Significant effect of IL-1 receptor antagonist treatment in two patients who had CINCA syndrome with constant symptoms for 13 years].
Idorn L; Vissing NH; Jensen L; Herlin T
Ugeskr Laeger; 2012 May; 174(22):1537-8. PubMed ID: 22668652
[TBL] [Abstract][Full Text] [Related]
2. Neonatal treatment of CINCA syndrome.
Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
[TBL] [Abstract][Full Text] [Related]
3. Muckle-Wells treatment with anakinra.
Eungdamrong J; Boyd KP; Meehan SA; Latkowski JA
Dermatol Online J; 2013 Dec; 19(12):20720. PubMed ID: 24365011
[TBL] [Abstract][Full Text] [Related]
4. [Cutaneous neutrophils infiltrates. Case 8. CINCA/NOMID syndrome].
Fraitag S
Ann Pathol; 2011 Jun; 31(3):203-7. PubMed ID: 21737003
[No Abstract] [Full Text] [Related]
5. [Cryopyrin-associated periodic syndromes].
Quartier P; Rodrigues F; Georgin-Lavialle S
Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
[TBL] [Abstract][Full Text] [Related]
6. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
[TBL] [Abstract][Full Text] [Related]
7. Cryopyrin-associated periodic syndrome: an autoinflammatory disease manifested as neutrophilic urticarial dermatosis with additional perieccrine involvement.
Kolivras A; Theunis A; Ferster A; Lipsker D; Sass U; Dussart A; André J
J Cutan Pathol; 2011 Feb; 38(2):202-8. PubMed ID: 21062341
[TBL] [Abstract][Full Text] [Related]
8. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA.
Goldbach-Mansky R
Curr Rheumatol Rep; 2011 Apr; 13(2):123-31. PubMed ID: 21538043
[TBL] [Abstract][Full Text] [Related]
9. Twenty year follow up of a patient with a new de-novo NLRP3 mutation (S595G) and CINCA syndrome.
Kanariou M; Dracou C; Spanou K; Möller J; Rösen-Wolff A; Schuster V; Roesler J
Klin Padiatr; 2009; 221(6):379-81. PubMed ID: 19890791
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characterization of Italian patients affected by CINCA syndrome.
Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L
Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754
[TBL] [Abstract][Full Text] [Related]
11. Chronic Infantile Neurological Cutaneous and Articular (CINCA) syndrome: a review.
Finetti M; Omenetti A; Federici S; Caorsi R; Gattorno M
Orphanet J Rare Dis; 2016 Dec; 11(1):167. PubMed ID: 27927236
[TBL] [Abstract][Full Text] [Related]
12. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
Koné-Paut I; Galeotti C
Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
[TBL] [Abstract][Full Text] [Related]
13. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
[TBL] [Abstract][Full Text] [Related]
14. [Exacerbation of skin lesions during fever in a patient with chronic infantile neurologic cutaneous articular (CINCA) syndrome].
Aboín-González S; Aldanondo-Fernández de la Mora I; García-Acebes CR; Carrillo-Gijón R; Harto-Castaño A; Jaén-Olasolo P
Actas Dermosifiliogr; 2008; 99(6):481-4. PubMed ID: 18558058
[TBL] [Abstract][Full Text] [Related]
15. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
[No Abstract] [Full Text] [Related]
16. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
[TBL] [Abstract][Full Text] [Related]
17. Neonatal urticaria: Could it be CAPS?
Cutts L; Parslew R; Eustace K
Pediatr Dermatol; 2018 Nov; 35(6):e420-e421. PubMed ID: 30187963
[TBL] [Abstract][Full Text] [Related]
18. [Update in interleukin-1 inhibition].
de Boysson H
Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
[No Abstract] [Full Text] [Related]
19. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra.
Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I
Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084
[TBL] [Abstract][Full Text] [Related]
20. [Muckle-Wells syndrome caused by a new cryopyrin mutation: effective treatment with interleukin-1 antagonist].
Rameev VV; Kozlovskaia LV; Bogdanova MV
Ter Arkh; 2012; 84(6):53-9. PubMed ID: 22997920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
